Google+ Facebook Twitter Twitter

Mode of action for diabetes drug

Researchers have discovered a mechanism that may explain how the frontline type 2 diabetes drug metformin works to help cells better take up and use glucose.

The findings could potentially help explain metformin’s action in preventing a variety of chronic diseases, including cancers.

Scientists at the Francis Crick Institute and University of Montreal developed a new method that analyses how all of a cell’s biochemical processes respond to a particular drug at the same time.

The technology measures changes in the binding properties of all proteins to each other simultaneously. This enables scientists to identify molecular signatures that reveal how drugs influence cells.

This was applied to two metabolic drugs, one with a known mechanism of action, the immunosuppressant, rapamycin, and one with no known mechanism of action, metformin.

They found that metformin makes yeast cells act as if they are starved of the essential mineral iron. Further analysis revealed that metformin has a global effect on iron distributions in cells, which has a knock-on impact on iron-dependent biochemical processes.

Picture credit | Science Photo Library

Related Articles

Hens that lay human proteins in eggs offer future therapy hope

Chickens that are genetically modified to produce human proteins in their eggs can offer a cost-effective method of producing certain types of drugs, research suggests.

NHS to launch paid-for genomics tests

Healthy people in England will be able to pay the NHS to sequence their genes, on condition they share their data.

Biomarker for genome instability

Elevated levels of a protein called ubiquilin-4 can be a biomarker for genome instability, a Tel Aviv University study shows.

Combining optical, ultrasound technology

Researchers are developing a novel biomedical imaging system that combines optical and ultrasound technology to improve diagnosis of life-threatening diseases.